DEA May Issue More Cannabis Importing Licenses



The Drug Enforcement Administration announced this week that it was now accepting comments on a Virginia-based biotechnology company’s application to import “marihuana extract” and “tetrahydrocannabinol.”

In a small notice published in the government’s daily Federal Register report, the DEA stated that Sanyal Biotechnology was looking to import cannabis extracts and THC to use in the organization’s research on liver diseases.

According to the DEA’s Diversion Control Division, Sanyal Biotechnology is the second company this year to request to import the two cannabis-based substances. The other company, Noramco, also requested permission to import whole plant marijuana. >>>


  • LinkedIn - White Circle
21972-312_SOC_NonCPA.png
Cannabis Banking, Simplified.

Shield's purpose built compliance platform manages the risk, compliance and operational demands associated with banking in the legalized cannabis industry. With Shield's transactional and operational transparency tools, compliance officers are notified of non-compliant activity quickly. 

© 2019 Shield Compliance, LLC ||| 500 Union St., Ste 310 Seattle WA 98101

Website development and management by FI Partners, LLC